EIF2AK2 Missense Variants Associated with Early Onset Generalized Dystonia.
Adolescent
Adult
Age of Onset
Asian People
Brain
/ diagnostic imaging
Child
Child, Preschool
Dystonic Disorders
/ genetics
Female
Fibroblasts
/ metabolism
Genome-Wide Association Study
Humans
Infant
Magnetic Resonance Imaging
Male
Middle Aged
Mutation, Missense
Pedigree
White People
Exome Sequencing
Young Adult
eIF-2 Kinase
/ genetics
Journal
Annals of neurology
ISSN: 1531-8249
Titre abrégé: Ann Neurol
Pays: United States
ID NLM: 7707449
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
09
09
2020
revised:
05
11
2020
accepted:
22
11
2020
pubmed:
26
11
2020
medline:
2
4
2021
entrez:
25
11
2020
Statut:
ppublish
Résumé
The study was undertaken to identify a monogenic cause of early onset, generalized dystonia. Methods consisted of genome-wide linkage analysis, exome and Sanger sequencing, clinical neurological examination, brain magnetic resonance imaging, and protein expression studies in skin fibroblasts from patients. We identified a heterozygous variant, c.388G>A, p.Gly130Arg, in the eukaryotic translation initiation factor 2 alpha kinase 2 (EIF2AK2) gene, segregating with early onset isolated generalized dystonia in 5 patients of a Taiwanese family. EIF2AK2 sequencing in 191 unrelated patients with unexplained dystonia yielded 2 unrelated Caucasian patients with an identical heterozygous c.388G>A, p.Gly130Arg variant, occurring de novo in one case, another patient carrying a different heterozygous variant, c.413G>C, p.Gly138Ala, and one last patient, born from consanguineous parents, carrying a third, homozygous variant c.95A>C, p.Asn32Thr. These 3 missense variants are absent from gnomAD, and are located in functional domains of the encoded protein. In 3 patients, additional neurological manifestations were present, including intellectual disability and spasticity. EIF2AK2 encodes a kinase (protein kinase R [PKR]) that phosphorylates eukaryotic translation initiation factor 2 alpha (eIF2α), which orchestrates the cellular stress response. Our expression studies showed abnormally enhanced activation of the cellular stress response, monitored by PKR-mediated phosphorylation of eIF2α, in fibroblasts from patients with EIF2AK2 variants. Intriguingly, PKR can also be regulated by PRKRA (protein interferon-inducible double-stranded RNA-dependent protein kinase activator A), the product of another gene causing monogenic dystonia. We identified EIF2AK2 variants implicated in early onset generalized dystonia, which can be dominantly or recessively inherited, or occur de novo. Our findings provide direct evidence for a key role of a dysfunctional eIF2α pathway in the pathogenesis of dystonia. ANN NEUROL 2021;89:485-497.
Identifiants
pubmed: 33236446
doi: 10.1002/ana.25973
pmc: PMC7986743
doi:
Substances chimiques
EIF2AK2 protein, human
EC 2.7.11.1
eIF-2 Kinase
EC 2.7.11.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Video-Audio Media
Langues
eng
Sous-ensembles de citation
IM
Pagination
485-497Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2020 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Références
Lancet Neurol. 2018 Jul;17(7):597-608
pubmed: 29887161
Eur J Hum Genet. 2017 Feb;25(2):176-182
pubmed: 27848944
Cell Mol Life Sci. 2013 Oct;70(19):3493-511
pubmed: 23354059
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Neurobiol Dis. 2017 Feb;98:52-65
pubmed: 27890709
Mov Disord. 2013 Sep;28(10):1325-9
pubmed: 23736975
Lancet Neurol. 2008 Mar;7(3):207-15
pubmed: 18243799
Viruses. 2012 Oct 29;4(11):2598-635
pubmed: 23202496
Nat Rev Dis Primers. 2018 Sep 20;4(1):25
pubmed: 30237473
EMBO J. 1998 Aug 3;17(15):4379-90
pubmed: 9687506
Neuroscience. 2018 Feb 10;371:455-468
pubmed: 29289717
FEBS J. 2015 Dec;282(24):4766-81
pubmed: 26414443
Mol Cell. 2018 Feb 15;69(4):622-635.e6
pubmed: 29429924
Neurobiol Dis. 2020 Dec;146:105135
pubmed: 33049316
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
J Cell Biochem. 2019 Nov;120(11):19004-19018
pubmed: 31246344
Expert Rev Mol Med. 2017 Jul 20;19:e9
pubmed: 28724458
Ann Neurol. 2016 Feb;79(2):244-56
pubmed: 26528954
Mov Disord. 2016 May;31(5):765-7
pubmed: 26990861
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Nat Struct Mol Biol. 2009 Jan;16(1):63-70
pubmed: 19043413
Neurobiol Learn Mem. 2013 Oct;105:93-9
pubmed: 23707798
FEBS J. 2019 Jan;286(2):342-355
pubmed: 29476642
EMBO Rep. 2016 Oct;17(10):1374-1395
pubmed: 27629041
Neuron. 2016 Dec 21;92(6):1238-1251
pubmed: 27939583
J Biol Chem. 2015 Sep 11;290(37):22543-57
pubmed: 26231208
Am J Hum Genet. 2020 Apr 2;106(4):570-583
pubmed: 32197074
Curr Neurol Neurosci Rep. 2017 Oct 30;17(12):97
pubmed: 29086067
J Inherit Metab Dis. 2018 Nov;41(6):1077-1091
pubmed: 29948482
PLoS Genet. 2018 Jan 24;14(1):e1007169
pubmed: 29364887
Biochem J. 2002 Aug 15;366(Pt 1):175-86
pubmed: 11985496
Sci Rep. 2016 Sep 16;6:32886
pubmed: 27633668
Nat Genet. 2002 Jan;30(1):97-101
pubmed: 11731797
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Brain Res. 2019 Mar 1;1706:24-31
pubmed: 30366018
Mov Disord. 2019 Oct;34(10):1516-1527
pubmed: 31216378